• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number PLC271200
Device Problem Compatibility Problem (2960)
Patient Problem Aneurysm (1708)
Event Date 04/02/2019
Event Type  Injury  
Manufacturer Narrative
Patient medications include but are not limited to: lisinopril,norvasc, lidotral cream.According to the instructions for use (ifu) for the gore® excluder® aaa endoprostheses; adverse events that may occur include, but are not limited to include: endoleak.A review of the manufacturing records for the device(s) verified the lot(s) met all pre-release specifications.
 
Event Description
On (b)(6) 2016, this patient underwent endovascular treatment for an abdominal aortic aneurysm and was implanted with gore® excluder® aaa endoprosthesis featuring c3® delivery system.It was reported that the physician was unable to cannulate the contralateral gate and after multiple attempts, cannulation was abandoned.An additional trunk ipsilateral leg endoprosthesis was used to perform an unplanned aorto-uni-iliac (aui), with a femoral bypass.The procedure was successfully concluded with implant of a contralateral leg component on the right side.On (b)(6) 2019, magnetic resonance angiography (mra) showed a distal type i endoleak on the right side caused by a lack of apposition and seal.There was aneurysm growth reported but the amount is unknown.On (b)(6) 2019, the patient underwent re-intervention.The right side was extended with an additional contralateral leg component down to the right external iliac artery, with coverage of the right internal iliac artery; and the aui was wired.The patient tolerated the procedure and the endoleak was resolved.
 
Manufacturer Narrative
Date of event: additional/corrected information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER AAA ENDOPROSTHESIS (LOW PROFILE)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8618189
MDR Text Key145410777
Report Number2953161-2019-00039
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132618545
UDI-Public00733132618545
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 06/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/18/2019
Device Catalogue NumberPLC271200
Device Lot Number14889748
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/16/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received06/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age78 YR
Patient Weight77
-
-